TriSalus Life Sciences, Inc. (TLSI)
(Delayed Data from NSDQ)
$4.90 USD
-0.02 (-0.41%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $4.87 -0.03 (-0.61%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
TLSI 4.90 -0.02(-0.41%)
Will TLSI be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TLSI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TLSI
TriSalus Life Sciences, Inc. (TLSI) Reports Q2 Loss, Tops Revenue Estimates
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates
TLSI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zimmer Biomet (ZBH) Beats Q2 Earnings and Revenue Estimates
TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates
OrganiGram (OGI) Reports Q2 Loss, Beats Revenue Estimates (Revised)
Other News for TLSI
Is TLSI preparing to trend lower? 20 Day Moving Average Resistance shows up after dropping 0.41%
Is TLSI preparing to trend higher? Directional Movement Crossover Bullish shows up after rising 2.5%
TLSI forms Pocket Pivot on September 17
TLSI Crossed Above 50 Day Moving Average on September 16
50 Day Moving Average Resistance appears for TLSI after 3.84% move